Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Latest 13D and 13G Filings > 13G Filing (0000902664-24-001347)

Filing Details

Accession Number:
0000902664-24-001347
Form Type:
13G Filing
Publication Date:
2024-02-08 19:00:00
Filed By:
Falcon Edge Capital
Company:
Alto Neuroscience Inc.
Filing Date:
2024-02-09
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Alpha Wave Global 0 3,707,757 0 3,707,757 3,707,757 13.8%
Alpha Wave Ventures GP, Ltd 0 3,707,757 0 3,707,757 3,707,757 13.8%
Chimera Investment 0 3,707,757 0 3,707,757 3,707,757 13.8%
Lunate Holding RSC LTD 0 3,707,757 0 3,707,757 3,707,757 13.8%
Filing

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
SCHEDULE 13G
 
Under the Securities Exchange Act of 1934
(Amendment No. )*
 

Alto Neuroscience, Inc.

(Name of Issuer)
 

Common stock, par value $0.0001 per share

(Title of Class of Securities)
 

02157Q109

(CUSIP Number)
 

February 6, 2024

(Date of Event Which Requires Filing of this Statement)
 
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
¨ Rule 13d-1(b)
ý Rule 13d-1(c)
¨ Rule 13d-1(d)
 
(Page 1 of 9 Pages)

 

______________________________

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP No. 02157Q10913GPage 2 of 9 Pages

 

1

NAME OF REPORTING PERSON

Alpha Wave Global, LP

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH		 5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

3,707,757

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

3,707,757

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,707,757

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

13.8%

12

TYPE OF REPORTING PERSON

IA

         

 

 

 

CUSIP No. 02157Q10913GPage 3 of 9 Pages

 

 

1

NAME OF REPORTING PERSON

Alpha Wave Ventures GP, Ltd

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

Cayman Islands

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH		 5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

3,707,757

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

3,707,757

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,707,757

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

13.8%

12

TYPE OF REPORTING PERSON

OO

         

 

 

 

CUSIP No. 02157Q10913GPage 4 of 9 Pages

 

 

1

NAME OF REPORTING PERSON

Chimera Investment LLC

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

United Arab Emirates

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH		 5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

3,707,757

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

3,707,757

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,707,757

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

13.8%

12

TYPE OF REPORTING PERSON`

OO

         

 

 

 

CUSIP No. 02157Q10913GPage 5 of 9 Pages

 

 

1

NAME OF REPORTING PERSON

Lunate Holding RSC LTD

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

United Arab Emirates

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH		 5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

3,707,757

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

3,707,757

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,707,757

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

13.8%

12

TYPE OF REPORTING PERSON

OO

         

 

 

 

CUSIP No. 02157Q10913GPage 6 of 9 Pages

  

Item 1(a). Name of Issuer.
  Alto Neuroscience, Inc. (the "Issuer")
Item 1(b). Address of Issuer's Principal Executive Offices.
 

369 South San Antonio Road

Los Altos, CA 94022

 

Item 2(a). Name of Person Filing.
 

This statement is being filed by Alpha Wave Global, LP (“Alpha Wave”), Alpha Wave Ventures GP, Ltd (“Alpha Wave Ventures GP”), Chimera Investment LLC (“Chimera”) and Lunate Holding RSC LTD (“Lunate”, together with Alpha Wave Ventures GP, Alpha Wave and Chimera, the “Reporting Persons”) with respect to the securities held by Alpha Wave Ventures II, LP (“Alpha Wave Ventures”).

 

Alpha Wave Ventures GP is the general partner of Alpha Wave Ventures. Alpha Wave Ventures GP is a joint venture between Alpha Wave and Lunate. Lunate is a subsidiary of Chimera. Richard Gerson is the Chairman and Chief Investment Officer of Alpha Wave. Chimera is controlled by its board of directors.

   
  The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock reported herein.

 

Item 2(b). Address of Principal Business Office.
  The principal business office of Alpha Wave and Alpha Wave GP is 667 Madison Avenue, 19th Floor, New York, NY 10065. The principal business office for Chimera is Office 410, Royal Group Headquarters Building, Khalifa Park Area, Abu Dhabi, United Arab Emirates. The principal business office for Lunate is Unit No. 1, Floor 12, Al Maryah Tower, Abu Dhabi Global Market Square, Al Maryah Island, Abu Dhabi, United Arab Emirates.

 

Item 2(c). Place of Organization.
  Alpha Wave is a Delaware limited partnership. Alpha Wave GP is an exempted limited company organized under the laws of the Cayman Islands. Chimera is organized under the laws of the United Arab Emirates. Lunate is a company organized under the laws of the Abu Dhabi Global Market in the United Arab Emirates.

 

Item 2(d). Title of Class of Securities.
  Common stock, par value $0.0001 per share (the "Common Stock")
   
Item 2(e). CUSIP Number.
  02157Q109
   

 

 

 

CUSIP No. 02157Q10913GPage 7 of 9 Pages

  

Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a.
  (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
  (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
  (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
  (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
  (e) ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
  (f) ¨

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

 

  (g) ¨

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 

  (h) ¨

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);

 

  (i) ¨

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

  (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
  (k) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(K);
 

If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please

specify the type of institution;____________________________________________

 

Item 4. Ownership.
  The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentages set forth in this Schedule 13G are calculated based upon 26,780,360 shares of Common Stock outstanding as reported in the Issuer’s Prospectus filed pursuant to Rule  424(b)(4) with the Securities and Exchange Commission on February 5, 2024, and giving effect to the full exercise of the underwriters’ over-allotment option as disclosed on the investor relations page of the Issuer’s website.
   
Item 5. Ownership of Five Percent or Less of a Class.
  Not applicable.
   
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
  See Item 2(a).  
   
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
  Not applicable.

 

 

 

CUSIP No. 02157Q10913GPage 8 of 9 Pages

 

Item 8. Identification and Classification of Members of the Group.
  Not applicable.
   
Item 9. Notice of Dissolution of Group.
  Not applicable.
   
Item 10. Certification.
  By signing below each Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
   

 

 

CUSIP No. 02157Q10913GPage 9 of 9 Pages

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
   
Date:  February 8, 2024  
  Alpha Wave Global, LP
   
  By:  /s/ Richard Gerson
  Name:  Richard Gerson
  Title:    Richard Gerson, Chairman and CIO
   
   
  Alpha Wave Ventures GP, Ltd
   
  By:  /s/ Richard Gerson
  Name:  Richard Gerson
  Title:    Director
   
  Chimera Investment LLC
   
  By:  /s/ Syed Basar Shueb Syed Shueb
  Name:  Syed Basar Shueb Syed Shueb
  Title:    Director and Authorized Signatory
   
  Lunate Holding RSC LTD
   
  By:  /s/ Syed Basar Shueb Syed Shueb
  Name:  Syed Basar Shueb Syed Shueb
  Title:    Director and Authorized Signatory
 
 

EXHIBIT 99.1

JOINT FILING AGREEMENT

 

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.  The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
   
Date:  February 8, 2024  
  Alpha Wave Global, LP
   
  By:  /s/ Richard Gerson
  Name:  Richard Gerson
  Title:    Richard Gerson, Chairman and CIO
   
   
  Alpha Wave Ventures GP, Ltd
   
  By:  /s/ Richard Gerson
  Name:  Richard Gerson
  Title:    Director
   
  Chimera Investment LLC
   
  By:  /s/ Syed Basar Shueb Syed Shueb
  Name:  Syed Basar Shueb Syed Shueb
  Title:    Director and Authorized Signatory
   
  Lunate Holding RSC LTD
   
  By:  /s/ Syed Basar Shueb Syed Shueb
  Name:  Syed Basar Shueb Syed Shueb
  Title:    Director and Authorized Signatory